CRP and metabolic syndrome: Although subjects with reversibility did use more often inhaled corticosteroids (13.3% versus 4.4%, P = 0.032), there was no significant difference in FeNO, blood eosinophils, or CRP between subjects with and without the metabolic syndrome.